Consistent with this idea, recent studies have reported an increasing prevalence of A+T– MCI with advancing age,53, 54 perhaps due to the fact that LATE or other non‐AD pathologies, which are more common with advanced age, drive cognitive impairment in the absence of detectable tau pathology. This evidence concerns the gene MAPT and Cognitive impairment.